Key Success Factors for Regenerative Medicine in Acquired Heart Diseases.

Stem Cell Rev Rep · 2020 · PMC7253501 · PMID 32297205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

At the 12-month FU, only the 150 × 10 6 group showed a trend towards a small, but non-significant, improvement in TET and a lower incidence of MACE versus placebo.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.